Anticoagulant citrates. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy2

Blood Platelets Plasma

Organisms11

Sea Cucumbers Seaweed Phaeophyta Ancylostoma Strongylida Rabbits Leuconostoc Cattle Swine Agkistrodon Elapidae

Diseases39

Thromboembolism Hemorrhage Thrombosis Antiphospholipid Syndrome Thrombophlebitis Venous Thrombosis Thrombophilia Blood Coagulation Disorders Venous Thromboembolism Pulmonary Embolism Activated Protein C Resistance Atrial Fibrillation Protein C Deficiency Protein S Deficiency Antithrombin III Deficiency Hematoma Lupus Erythematosus, Systemic Stroke Hypoprothrombinemias Hemorrhagic Disorders Coagulation Protein Disorders Embolism Recurrence Postoperative Hemorrhage Cerebral Hemorrhage Hematoma, Subdural Intracranial Embolism and Thrombosis Pregnancy Complications, Hematologic Disseminated Intravascular Coagulation Abortion, Habitual Thrombocytopenia Cerebrovascular Disorders Sinus Thrombosis, Intracranial Intracranial Hemorrhages Pregnancy Complications, Cardiovascular Ischemic Attack, Transient Intracranial Hemorrhage, Traumatic Heart Diseases Factor V Deficiency

Chemicals and Drugs145

Anticoagulants Citrate (si)-Synthase Citric Acid Lupus Coagulation Inhibitor Warfarin Protein C Heparin Rodenticides Acenocoumarol Factor Xa Phenindione 4-Hydroxycoumarins Antithrombins Potassium Citrate Protein S Blood Coagulation Factors Heparin, Low-Molecular-Weight Thrombomodulin beta-Alanine Prothrombin Thrombin Oxo-Acid-Lyases Vitamin K Calcium Citrate Phenprocoumon Antithrombin III Antibodies, Antiphospholipid Antibodies, Anticardiolipin Heparin Antagonists Hirudins Thromboplastin Clomiphene Factor X Factor V Coagulants beta 2-Glycoprotein I Dicumarol Factor Va Fibrinolytic Agents Platelet Aggregation Inhibitors Pipecolic Acids Thiophenes Enoxaparin Vitamin K Epoxide Reductases Aspirin Tricarboxylic Acids Malates Dermatan Sulfate Heparin Cofactor II Benzimidazoles Pyridones Oxaloacetates Cardiolipins Gallium Radioisotopes Dalteparin Edetic Acid Polysaccharides Coumarins Ferric Compounds Arthropod Proteins Morpholines Antithrombin Proteins Aconitate Hydratase Factor VIIa Factor VIIIa Isocitrates Factor VII Fibrin Aluminum Fertility Agents, Female Citrates Fibrin Fibrinogen Degradation Products Isocitrate Dehydrogenase Recombinant Proteins Phospholipids Heparinoids Bismuth Heparitin Sulfate Oxaloacetic Acid Ancrod Ketoglutaric Acids Chromogenic Compounds Glycoproteins Protein C Inhibitor Serine Proteinase Inhibitors Fibrinogen Azetidines Sulfates Salivary Proteins and Peptides Malate Dehydrogenase Acetyl Coenzyme A Sulfones Factor IX Acetates Heparin Lyase Benzylamines Factor IXa Receptors, Thrombin Annexin A5 Hemostatics Coenzyme A Dicarboxylic Acid Transporters Cobra Venoms Viper Venoms Antidotes Factor VIII Aconitic Acid Protamines Blood Coagulation Factor Inhibitors Ranitidine Gallium Phosphofructokinase-1 Galactans Glycosaminoglycans Annexins Crotalid Venoms Complement Inactivator Proteins Pyruvates Autoantibodies Purines Sulfuric Acid Esters Iron Hexadimethrine Bromide Nadroparin Chondroitin Sulfates 1-Carboxyglutamic Acid Glucose Carrier Proteins Platelet Factor 4 Receptor, PAR-1 Vitamin K 1 Receptors, Cell Surface Thienopyridines Carboxylic Acids Fibrinopeptide A Sulfotransferases Drugs, Investigational Culture Media Calcium Chloride Anions Aptamers, Nucleotide Pyrazoles Immunoglobulin G Antifibrinolytic Agents Helminth Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment35

Prothrombin Time Partial Thromboplastin Time Blood Coagulation Tests Thrombin Time International Normalized Ratio Administration, Oral Drug Monitoring Blood Specimen Collection Treatment Outcome Whole Blood Coagulation Time Blood Preservation Risk Factors Heart Valve Prosthesis Prospective Studies Perioperative Care Retrospective Studies Bleeding Time Drug Therapy, Combination Follow-Up Studies Randomized Controlled Trials as Topic Hirudin Therapy Vena Cava Filters Magnetic Resonance Spectroscopy Risk Assessment Hemofiltration Drug Administration Schedule Clinical Trials as Topic Oral Surgical Procedures Platelet Count Chromatography, High Pressure Liquid Thrombolytic Therapy Phlebography Drug Substitution Thrombelastography Culture Media

Phenomena and Processes23

Blood Coagulation Prothrombin Time Partial Thromboplastin Time Thrombin Time Hemostasis Time Factors Kinetics Whole Blood Coagulation Time Dose-Response Relationship, Drug Fibrinolysis Hydrogen-Ion Concentration Amino Acid Sequence Protein Binding Bleeding Time Drug Interactions Pregnancy Platelet Activation Structure-Activity Relationship Platelet Aggregation Binding Sites Platelet Count Molecular Weight Mutation

Disciplines and Occupations1

Technology, Industry, Agriculture1

Hexadimethrine Bromide

Information Science2

Molecular Sequence Data Amino Acid Sequence

Health Care11

Rodent Control Treatment Outcome Risk Factors Prospective Studies Perioperative Care Retrospective Studies Follow-Up Studies Randomized Controlled Trials as Topic Risk Assessment Clinical Trials as Topic Drug Substitution

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Information Science Health Care

Anticoagulants Citrate (si)-Synthase Citric Acid Lupus Coagulation Inhibitor Blood Coagulation Warfarin Prothrombin Time Protein C Partial Thromboplastin Time Heparin Rodenticides Acenocoumarol Factor Xa Phenindione 4-Hydroxycoumarins Antithrombins Blood Coagulation Tests Potassium Citrate Thrombin Time International Normalized Ratio Thromboembolism Protein S Blood Coagulation Factors Hemorrhage Heparin, Low-Molecular-Weight Thrombosis Thrombomodulin beta-Alanine Prothrombin Thrombin Antiphospholipid Syndrome Oxo-Acid-Lyases Vitamin K Calcium Citrate Thrombophlebitis Phenprocoumon Venous Thrombosis Antithrombin III Antibodies, Antiphospholipid Administration, Oral Antibodies, Anticardiolipin Thrombophilia Blood Coagulation Disorders Venous Thromboembolism Pulmonary Embolism Heparin Antagonists Hirudins Thromboplastin Clomiphene Factor X Factor V Coagulants beta 2-Glycoprotein I Dicumarol Activated Protein C Resistance Atrial Fibrillation Factor Va Hemostasis Fibrinolytic Agents Platelet Aggregation Inhibitors Rodent Control Pipecolic Acids Thiophenes Enoxaparin Vitamin K Epoxide Reductases Protein C Deficiency Aspirin Tricarboxylic Acids Malates Dermatan Sulfate Heparin Cofactor II Benzimidazoles Pyridones Protein S Deficiency Oxaloacetates Cardiolipins Antithrombin III Deficiency Hematoma Time Factors Drug Monitoring Gallium Radioisotopes Dalteparin Kinetics Sea Cucumbers Lupus Erythematosus, Systemic Edetic Acid Polysaccharides Coumarins Blood Specimen Collection Treatment Outcome Ferric Compounds Stroke Arthropod Proteins Hypoprothrombinemias Morpholines Antithrombin Proteins Whole Blood Coagulation Time Aconitate Hydratase Blood Preservation Factor VIIa

No FAQ available that match "anticoagulant citrates"